BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17:343-351. [PMID: 26831295 DOI: 10.1007/s11154-016-9328-5] [Cited by in Crossref: 89] [Cited by in F6Publishing: 59] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis 2019;10:2040622319830646. [PMID: 30854183 DOI: 10.1177/2040622319830646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
2 Montero-Vilchez T, Valenzuela-Amigo A, Cuenca-Barrales C, Arias-Santiago S, Leyva-García A, Molina-Leyva A. The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study. Life (Basel) 2021;11:697. [PMID: 34357069 DOI: 10.3390/life11070697] [Reference Citation Analysis]
3 Fotiadou C, Vakirlis E, Ioannides D. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa. Clin Cosmet Investig Dermatol 2016;9:367-72. [PMID: 27799806 DOI: 10.2147/CCID.S93619] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
4 Albrecht J, Baine PA, Ladizinski B, Jemec GB, Bigby M. Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa. A Critically Appraised Topic. Br J Dermatol 2019;180:749-55. [PMID: 30281779 DOI: 10.1111/bjd.17265] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
5 Zupin L, Ferri G, Tricarico PM, Gratton R, Nait-Meddour C, Ottaviani G, Crovella S. Impact of 970 nm photobiomodulation therapy on wound healing in cellular models of hidradenitis suppurativa. Lasers Med Sci 2021;36:691-8. [PMID: 32647934 DOI: 10.1007/s10103-020-03097-w] [Reference Citation Analysis]
6 Pink A, Anzengruber F, Navarini A. Acne and hidradenitis suppurativa. Br J Dermatol 2018;178:619-31. [DOI: 10.1111/bjd.16231] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
7 Iannone M, Janowska A, Bartolomei G, Puntoni M, Oranges T, Romanelli M, Dini V. Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy. Dermatol Ther 2021;34:e14919. [PMID: 33634552 DOI: 10.1111/dth.14919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Penno CA, Jäger P, Laguerre C, Hasler F, Hofmann A, Gass SK, Wettstein-Ling B, Schaefer DJ, Avrameas A, Raulf F, Wieczorek G, Lehmann JCU, Loesche C, Roth L, Röhn TA. Lipidomics Profiling of Hidradenitis Suppurativa Skin Lesions Reveals Lipoxygenase Pathway Dysregulation and Accumulation of Proinflammatory Leukotriene B4. J Invest Dermatol 2020;140:2421-2432.e10. [PMID: 32387270 DOI: 10.1016/j.jid.2020.04.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
9 Kyriakou A, Trigoni A, Galanis N, Sotiriadis D, Patsatsi A. Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: Real life data. Dermatol Reports 2018;10:7859. [PMID: 30370041 DOI: 10.4081/dr.2018.7859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
10 Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol 2021;39:240-7. [PMID: 34272017 DOI: 10.1016/j.clindermatol.2020.10.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Crowley EL, O'Toole A, Gooderham MJ. Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections. SAGE Open Med Case Rep. 2018;6:2050313X18778723. [PMID: 29922466 DOI: 10.1177/2050313x18778723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
12 Grimstad Ø, Kvammen BØ, Swartling C. Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study. Am J Clin Dermatol 2020;21:741-8. [PMID: 32761500 DOI: 10.1007/s40257-020-00537-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
13 Dauden E, Lazaro P, Aguilar M, Blasco A, Suarez C, Marin I, Queiro R, Bassas-vila J, Martorell A, García-campayo J. Recommendations for the management of comorbidity in hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2018;32:129-44. [DOI: 10.1111/jdv.14517] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
14 Vekic DA, Cains GD. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 2. Australas J Dermatol. 2018;59:261-266. [PMID: 29363099 DOI: 10.1111/ajd.12766] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Bosnić D, Žarković B, Barešić M, Zarkovic M, Anić B. Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab. Reumatologia 2016;54:321-5. [PMID: 28115784 DOI: 10.5114/reum.2016.64910] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
16 Marvel J, Vlahiotis A, Sainski-Nguyen A, Willson T, Kimball A. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data. BMJ Open 2019;9:e030579. [PMID: 31575575 DOI: 10.1136/bmjopen-2019-030579] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
17 Marasca C, Tranchini P, Marino V, Annunziata MC, Napolitano M, Fattore D, Fabbrocini G. The pharmacology of antibiotic therapy in hidradenitis suppurativa. Expert Review of Clinical Pharmacology 2020;13:521-30. [DOI: 10.1080/17512433.2020.1762571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
18 van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021;85:369-78. [PMID: 33484766 DOI: 10.1016/j.jaad.2020.12.089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Balcere A, Upeniece I, Snipe K, Jezupovs A. Hidradenitis suppurativa in surgeons' practice: Prevalence and treatment approach according to the Hurley stage in Latvia. Dermatol Ther 2021;34:e14687. [PMID: 33331018 DOI: 10.1111/dth.14687] [Reference Citation Analysis]
20 Nikolakis G, von Stebut E. [Topical and novel device-based therapies for mild hidradenitis suppurativa]. Hautarzt 2021;72:676-85. [PMID: 34223936 DOI: 10.1007/s00105-021-04849-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE. Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. J Am Acad Dermatol 2019;80:60-69.e2. [PMID: 29860040 DOI: 10.1016/j.jaad.2018.05.040] [Cited by in Crossref: 68] [Cited by in F6Publishing: 52] [Article Influence: 22.7] [Reference Citation Analysis]
22 Smith MK, Nicholson CL, Parks-Miller A, Hamzavi IH. Hidradenitis suppurativa: an update on connecting the tracts. F1000Res. 2017;6:1272. [PMID: 28794864 DOI: 10.12688/f1000research.11337.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
23 Esposito C, Del Conte F, Cerulo M, Coppola V, Esposito G, Ricciardi E, Castagnetti M, Fabbrocini G, Escolino M. Pediatric Endoscopic Hidradenitis Treatment: A New Minimally Invasive Treatment for Pediatric Patients with Hidradenitis Suppurativa. J Laparoendosc Adv Surg Tech A 2020;30:464-70. [PMID: 32017645 DOI: 10.1089/lap.2019.0614] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Han R, Blencke HM, Cheng H, Li C. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris. Peptides 2018;99:36-43. [PMID: 29108811 DOI: 10.1016/j.peptides.2017.11.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
25 Gulliver W, Landells IDR, Morgan D, Pirzada S. Hidradenitis Suppurativa: A Novel Model of Care and an Integrative Strategy to Adopt an Orphan Disease. J Cutan Med Surg 2018;22:71-7. [PMID: 29056071 DOI: 10.1177/1203475417736290] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
26 Włodarek K, Ponikowska M, Matusiak Ł, Szepietowski JC. Biologics for hidradenitis suppurativa: an update. Immunotherapy 2019;11:45-59. [PMID: 30702012 DOI: 10.2217/imt-2018-0090] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
27 Arenbergerova M, Gkalpakiotis S, Marques E, Arenberger P, Dahmen R, Smetanova A. Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumab. J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.17151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Prens EP, Lugo-Somolinos AM, Paller AS, Kerdel F, Duan Y, Teixeira HD, Longcore M, Kimball AB. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice. Am J Clin Dermatol 2020;21:579-90. [PMID: 32077014 DOI: 10.1007/s40257-020-00504-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
29 Gkini MA, Bewley AP. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction? Dermatol Ther 2018;31:e12742. [PMID: 30221819 DOI: 10.1111/dth.12742] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Alavi A, Lynde C, Alhusayen R, Bourcier M, Delorme I, George R, Gooderham M, Gulliver W, Kalia S, Marcoux D, Poulin Y. Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document. J Cutan Med Surg 2017;21:513-24. [PMID: 28639459 DOI: 10.1177/1203475417716117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
31 Prignano F, Pescitelli L, Giani I, Dini V, Romanelli M; and the Tuscany HS Working Group. Tuscan consensus on the diagnosis and treatment of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2019;33 Suppl 6:21-4. [PMID: 31535762 DOI: 10.1111/jdv.15825] [Reference Citation Analysis]
32 Suárez Valladares MJ, Eiris Salvado N, Rodríguez Prieto MA. Treatment of hidradenitis suppurativa with intralesional photodynamic therapy with 5-aminolevulinic acid and 630nm laser beam. Journal of Dermatological Science 2017;85:241-6. [DOI: 10.1016/j.jdermsci.2016.12.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
33 Wieczorek M, Walecka I. Hidradenitis suppurativa - known and unknown disease. Reumatologia 2018;56:337-9. [PMID: 30647478 DOI: 10.5114/reum.2018.80709] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Neves JM, Cunha N, Lencastre A, Cabete J. Paradoxical hidradenitis suppurativa to biologic agents: a case series and literature review. Int J Dermatol 2019;58. [DOI: 10.1111/ijd.14585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Savage KT, Singh V, Patel ZS, Yannuzzi CA, McKenzie-Brown AM, Lowes MA, Orenstein LAV. Pain management in hidradenitis suppurativa and a proposed treatment algorithm. J Am Acad Dermatol 2021;85:187-99. [PMID: 32950543 DOI: 10.1016/j.jaad.2020.09.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
36 Garcovich S, Giovanardi G, Malvaso D, De Simone C, Peris K. Apremilast for the treatment of hidradenitis suppurativa associated with psoriatic arthritis in multimorbid patients: Case report and review of literature. Medicine (Baltimore) 2020;99:e18991. [PMID: 32000436 DOI: 10.1097/MD.0000000000018991] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
37 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
38 Marasca C, Annunziata MC, Napolitano M, Fabbrocini G. Unconventional therapies for hidradenitis suppurativa. Expert Review of Clinical Pharmacology 2018;11:879-87. [DOI: 10.1080/17512433.2018.1509706] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
39 Perng P, Zampella JG, Okoye GA. Management of hidradenitis suppurativa in pregnancy. Journal of the American Academy of Dermatology 2017;76:979-89. [DOI: 10.1016/j.jaad.2016.10.032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
40 Zouboulis CC, Tzellos T, Kyrgidis A, Jemec GBE, Bechara FG, Giamarellos-Bourboulis EJ, Ingram JR, Kanni T, Karagiannidis I, Martorell A, Matusiak Ł, Pinter A, Prens EP, Presser D, Schneider-Burrus S, von Stebut E, Szepietowski JC, van der Zee HH, Wilden SM, Sabat R; European Hidradenitis Suppurativa Foundation Investigator Group. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity. Br J Dermatol 2017;177:1401-9. [PMID: 28636793 DOI: 10.1111/bjd.15748] [Cited by in Crossref: 117] [Cited by in F6Publishing: 89] [Article Influence: 29.3] [Reference Citation Analysis]
41 Zouboulis CC, Bechara FG, Dickinson-Blok JL, Gulliver W, Horváth B, Hughes R, Kimball AB, Kirby B, Martorell A, Podda M, Prens EP, Ring HC, Tzellos T, van der Zee HH, van Straalen KR, Vossen ARJV, Jemec GBE. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group. J Eur Acad Dermatol Venereol 2019;33:19-31. [PMID: 30176066 DOI: 10.1111/jdv.15233] [Cited by in Crossref: 67] [Cited by in F6Publishing: 46] [Article Influence: 22.3] [Reference Citation Analysis]
42 Vinkel C, Thomsen SF. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne. Int J Dermatol 2017;56:811-8. [PMID: 28345207 DOI: 10.1111/ijd.13603] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
43 Koceva I, Rümmelein B, Gerber PA, Edge D, Nielsen MCE. Fluorescent light energy: A new therapeutic approach to effectively treating acne conglobata and hidradenitis suppurativa. Clin Case Rep 2019;7:1769-72. [PMID: 31534746 DOI: 10.1002/ccr3.2334] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
44 Vural S, Gündoğdu M, Akay BN, Boyvat A, Erdem C, Koçyiğit P, Bostancı S, Sanli H, Kundakci N. Hidradenitis suppurativa: Clinical characteristics and determinants of treatment efficacy. Dermatologic Therapy 2019;32. [DOI: 10.1111/dth.13003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
45 Grimstad Ø, Tzellos T, Dufour DN, Bremnes Ø, Skoie IM, Snekvik I, Jarnaess E, Kyrgidis A, Ingvarsson G. Evaluation of medical and surgical treatments for hidradenitis suppurativa using real-life data from the Scandinavian registry (HISREG). J Eur Acad Dermatol Venereol 2019;33:1164-71. [PMID: 30451320 DOI: 10.1111/jdv.15353] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
46 Lee EH, Lee SH, Sohng C, Kim JY, Park KD, Lee SJ, Lee WJ. Extensive Nevus Comedonicus with Inflammatory Nodules and Cysts Controlled with Adalimumab. Ann Dermatol 2021;33:361-4. [PMID: 34341638 DOI: 10.5021/ad.2021.33.4.361] [Reference Citation Analysis]
47 Boen M, Brownell J, Patel P, Tsoukas MM. The Role of Photodynamic Therapy in Acne: An Evidence-Based Review. Am J Clin Dermatol 2017;18:311-21. [DOI: 10.1007/s40257-017-0255-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
48 Hessam S, Sand M, Skrygan M, Gambichler T, Bechara FG. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. Inflammation 2017;40:464-72. [PMID: 28028756 DOI: 10.1007/s10753-016-0492-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
49 Andersen RK, Jemec GB. Treatments for hidradenitis suppurativa. Clin Dermatol 2017;35:218-24. [PMID: 28274363 DOI: 10.1016/j.clindermatol.2016.10.018] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
50 Iannone M, Janowska A, Oranges T, Balderi L, Benincasa BB, Vitali S, Tonini G, Morganti R, Romanelli M, Dini V. Ultrasound-guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study. Dermatol Ther 2021;:e15068. [PMID: 34297465 DOI: 10.1111/dth.15068] [Reference Citation Analysis]
51 Zouboulis CC, Stratakis CA, Chrousos GP, Koch CA. Metabolism and skin diseases. Rev Endocr Metab Disord 2016;17:241-6. [DOI: 10.1007/s11154-016-9396-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
52 Jemec GBE. Evidence-based hidradenitis suppurativa guidelines - and now all together please. Br J Dermatol 2019;180:975. [PMID: 31025736 DOI: 10.1111/bjd.17734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 van Straalen KR, Schneider-Burrus S, Prens EP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol 2020;183:e178-87. [PMID: 29981245 DOI: 10.1111/bjd.16768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
54 Matusiak Ł, Jemec GB, Szepietowski JC. Pharmacological development in hidradenitis suppurativa. Current Opinion in Pharmacology 2019;46:65-72. [DOI: 10.1016/j.coph.2019.04.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
55 Bouazzi D, Chafranska L, Saunte DML, Jemec GBE. Systematic Review of Complications and Recurrences After Surgical Interventions in Hidradenitis Suppurativa. Dermatol Surg 2020;46:914-21. [PMID: 32049703 DOI: 10.1097/DSS.0000000000002323] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
56 Nikolakis G, Kokolakis G, Kaleta K, Wolk K, Hunger R, Sabat R, Zouboulis CC. [Pathogenesis of hidradenitis suppurativa/acne inversa]. Hautarzt 2021;72:658-65. [PMID: 34228138 DOI: 10.1007/s00105-021-04853-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Hessam S, Bechara FG. [Hidradenitis suppurativa/acne inversa in the genitoanal region]. Hautarzt 2020;71:256-62. [PMID: 32077977 DOI: 10.1007/s00105-020-04556-9] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
58 Karvar M, Panayi AC, Alavi A, Baziar Z, Orgill DP. Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review. Int J Dermatol 2020. [PMID: 33615455 DOI: 10.1111/ijd.15293] [Reference Citation Analysis]
59 Gracia Cazaña T, Berdel Díaz L, Martín Sánchez J, Querol Nasarre I, Gilaberte Y. Revisión sistemática de las terapias con luz en el tratamiento de la hidradenitis supurativa. Actas Dermo-Sifiliográficas 2020;111:89-106. [DOI: 10.1016/j.ad.2019.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]